MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ · Healthcare · Biotechnology · TW
$2.39
+5.29%Institutional positioning
13F filings over the trailing two quarters
New 4Increased 6Reduced 7Sold out 17
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 258,760 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 64,232 | May 15, 2026 |
| UBS GROUP AG | Reduced | 37,363 | May 5, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 14,590 | May 15, 2026 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | New Position | 13,927 | May 14, 2026 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | Increased | 13,173 | Apr 28, 2026 |
| HRT FINANCIAL LP | New Position | 11,767 | May 14, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 11,703 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 6,301 | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 5,679 | May 13, 2026 |
| BARCLAYS PLC | Increased | 5,189 | May 15, 2026 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | Increased | 3,872 | May 4, 2026 |
| CITIGROUP INC | Reduced | 2,787 | May 11, 2026 |
| BNP PARIBAS ARBITRAGE, SNC | Increased | 1,881 | May 12, 2026 |
| GF FUND MANAGEMENT CO. LTD. | Increased | 1,677 | Apr 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings